EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis

Walter Masson, Martín Lobo, Juan Patricio Nogueira, Alfredo Matias Rodriguez-Granillo, Leandro Ezequiel Barbagelata, Daniel Siniawski

Frontiers in Cardiovascular Medicine · 05.07.2024 · 11

DOI: 10.3389/fcvm.2024.1379189 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 05.07.2024. Verfasst von Walter Masson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The anti-inflammatory effect could be one of the mechanisms by which semaglutide reduces cardiovascular risk in patients with type 2 diabetes mellitus (T2DM) and/or obesity. Determining the anti-inflammatory effect of semaglutide was the objective of this systematic review and meta-analysis.

Methods

This meta-analysis was performed according to the PRISMA guidelines. A literature search was performed to detect randomised clinical trials that have quantified the effect of semaglutide on C-reactive protein (CRP) levels compared to placebo or a control group (other glucose-lowering drugs). The primary outcome was CRP index (final CRP/basal CRP). A random-effects model was used.

Results

Thirteen randomised clinical trials were considered eligible ( n = 26,131). Overall, semaglutide therapy was associated with lower CRP index values compared to the placebo group (SMD −0.56; 95% CI −0.69 to −0.43, I 2 92%) or the control group (SMD −0.45; 95% CI −0.68 to −0.23, I 2 82%).Such an association was similarly observed when different treatment regimens (subcutaneous vs. oral) or different populations (patients with or without T2DM) were analysed. The sensitivity analysis showed that the results were robust.

Conclusion

The present meta-analysis demonstrated that the use of semaglutide was associated with a reduction in inflammation irrespective of the population evaluated or the treatment regimen used. These findings would explain one of the mechanisms by which semaglutide reduces cardiovascular events. Systematic Review Registration PROSPERO [CRD42024500551].

Schlagwörter

Stichwörter der Autor:innen

C-reactive proteinglucagon-like peptide-1 receptor agonistsinflammationmeta-analysissemaglutide

Autor:innen und Institutionen

  • Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Department of Cardiology, Hospital Militar Campo de Mayo, Buenos Aires, Argentina.
  • Endocrinology, Nutrition and Metabolism Research Center, Faculty of Health Sciences, Universidad Nacional de Formosa, Formosa, Argentina.
  • Medicine and Surgery Department, Universidad Internacional de las Américas, San José, Costa Rica.
  • Clinical Research Department, Centro de Estudios en Cardiologia Intervencionista (CECI), Buenos Aires, Argentina.
  • Department of Interventional Cardiology, Sanatorio Otamendi, Buenos Aires, Argentina.

Zitieren

APA

Masson, W., Lobo, M., Nogueira, J. P., Rodriguez-Granillo, A. M., Barbagelata, L. E., & Siniawski, D. (2024). Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1379189

Vancouver

Masson W, Lobo M, Nogueira JP, Rodriguez-Granillo AM, Barbagelata LE, Siniawski D. Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1379189

BibTeX
@article{Masson2024,
  author = {Masson, Walter and Lobo, Martín and Nogueira, Juan Patricio and Rodriguez-Granillo, Alfredo Matias and Barbagelata, Leandro Ezequiel and Siniawski, Daniel},
  title = {Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2024},
  volume = {11},
  doi = {10.3389/fcvm.2024.1379189}
}
Kostenlos starten →